SOSV

InnSight Technology is a biotechnology company focused on advancing the diagnostics and evaluation of eye diseases. The company specializes in developing innovative ophthalmic devices, including a novel, hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on the development of nanotechnology-based medical devices aimed at addressing various clinical needs in ophthalmology. By providing these advanced tools, the company enables clinicians to enhance ocular care and improve patient outcomes in eye health.

Kfobix is a technology company specializing in the development and application of advanced nanocomposite coatings for enhancing the durability and efficiency of energy infrastructure. The company's flagship product is a patented superhydrophobic coating, designed to prevent ice formation and water accumulation on surfaces such as wind turbine blades and power lines. This coating, applied via a simple spray method, offers high transparency, long-lasting durability, and ease of application, thereby reducing maintenance costs and operational disruptions in the energy sector. Additionally, Kfobix is pioneering anti-dirt coatings for solar panels, aiming to maximize their efficiency and output. The company's mission is to facilitate a seamless transition to renewable energy sources by addressing some of the most pressing challenges in the sector, ultimately promoting a cleaner, more reliable, and sustainable energy future.

NanoPlume is a biomaterial manufacturer specializing in the large-scale production of innovative, eco-friendly biomaterials, notably Bio-Aerogel. The company focuses on creating advanced insulating biomaterials and aerogels, aiming to enhance energy and space efficiency, as well as promote circularity across various industries. By utilizing organic and recycled feedstocks and green technology, NanoPlume reduces waste and minimizes energy consumption. Its products are designed to insulate cargo boxes in the cold chain healthcare logistics sector, reducing payload and energy consumption, and extending battery range.

Minutia is a biotechnology company focused on developing innovative stem cell-derived transplants aimed at treating Type 1 Diabetes. The company specializes in creating insulin-producing cell transplants that incorporate proprietary nanosensors, allowing for real-time monitoring of transplant status. These immune-evasive cells are designed for subcutaneous implantation, addressing common challenges associated with transplant procedures. By advancing this technology, Minutia seeks to transform the clinical landscape for diabetes management and cell replacement therapies, ultimately working towards a functional cure for this condition.

Mesa Quantum is an electronics manufacturing company specializing in quantum technology solutions. The company develops advanced photonic quantum computing hardware, which aims to transform computing capabilities by offering an integrated photonic quantum computing chip designed to encode and manipulate quantum information. This innovative technology presents significant advantages in scalability and stability, enabling customers to leverage quantum computing to address complex problems that traditional computers cannot effectively solve. Mesa Quantum's focus on quantum sensors and chip-scale technology positions it at the forefront of the rapidly evolving quantum computing landscape.

Hidrogenics is a clean energy company specializing in methane pyrolysis technology. It converts methane into clean hydrogen and solid carbon products, such as synthetic graphite, carbon nanotubes, and graphene. The company's multi-metal catalyst-based process enables industries to decarbonize and transition towards green energy.

Level Zero Health is a technology company specializing in advanced biosensor solutions. It develops wearable devices equipped with DNA-based sensors, designed to precisely monitor key endocrine biomarkers in real-time. By combining biochemistry and nanotechnology, the company collects novel data, empowering users to gain insights into their hormonal health.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

Allozymes is a pioneering company specializing in advanced microfluidics technology. It accelerates enzyme evolution and development by creating sensitive assays for detecting enzymatic reactions, proprietary microfluidic chips, and proteomics technologies.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Gozen Bioworks offers solutions and biomaterials developed with a biomimicry approach by combining science, art, philosophy, and design to raise awareness and provide help to the planet, living creatures, and humanity. They develop and invent high-performance microbe-derived materials from natural inputs, such as next-generation leather, biotextiles, bioplastics, packaging, and interior materials.

SepPure disrupts energy-intensive chemical separation processes like distillation. It uses novel nanofiltration membranes for sustainable separations, reducing global energy consumption, emissions, and pollution.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Gozen Bioworks offers solutions and biomaterials developed with a biomimicry approach by combining science, art, philosophy, and design to raise awareness and provide help to the planet, living creatures, and humanity. They develop and invent high-performance microbe-derived materials from natural inputs, such as next-generation leather, biotextiles, bioplastics, packaging, and interior materials.

Vader Nanotechnologies focuses on developing innovative organisms and enzymes aimed at addressing environmental challenges, particularly in recycling plastics and degrading persistent chemicals like PFAS. The company employs advanced techniques such as automation, image processing, computer vision, and analytical chemistry to identify and optimize strains capable of thriving on these difficult-to-break-down substances. By utilizing directed evolution methods, Vader enhances the performance of these organisms, contributing to solutions that tackle pressing environmental and health issues.

Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

SepPure disrupts energy-intensive chemical separation processes like distillation. It uses novel nanofiltration membranes for sustainable separations, reducing global energy consumption, emissions, and pollution.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Allozymes is a pioneering company specializing in advanced microfluidics technology. It accelerates enzyme evolution and development by creating sensitive assays for detecting enzymatic reactions, proprietary microfluidic chips, and proteomics technologies.

Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

Allozymes is a pioneering company specializing in advanced microfluidics technology. It accelerates enzyme evolution and development by creating sensitive assays for detecting enzymatic reactions, proprietary microfluidic chips, and proteomics technologies.

BioFeyn develops aquafeed ingredients that enhance the nutrition and sustainability of farmed fish. By optimizing marine ingredients and applying biodegradable nanoencapsulation, the company improves digestion, absorption, and bioavailability of nutrients, enabling delivery to specific tissues. This targeted delivery supports healthier growth and disease prevention in fish while reducing environmental pollution. The approach combines modular nutrient delivery with natural disease preventatives, helping clients produce farmed fish that are both nutritious and more sustainable.

Kraken Sense develops an automated pathogen detection platform that uses cutting-edge nanotechnology and IoT-enabled dashboard for real-time bacterial contamination monitoring.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

BioFeyn develops aquafeed ingredients that enhance the nutrition and sustainability of farmed fish. By optimizing marine ingredients and applying biodegradable nanoencapsulation, the company improves digestion, absorption, and bioavailability of nutrients, enabling delivery to specific tissues. This targeted delivery supports healthier growth and disease prevention in fish while reducing environmental pollution. The approach combines modular nutrient delivery with natural disease preventatives, helping clients produce farmed fish that are both nutritious and more sustainable.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Allozymes is a pioneering company specializing in advanced microfluidics technology. It accelerates enzyme evolution and development by creating sensitive assays for detecting enzymatic reactions, proprietary microfluidic chips, and proteomics technologies.

MicroSynbiotiX Limited, founded in 2016 and based in Cork City, Ireland, focuses on the development of oral vaccines specifically for the aquaculture sector. The company leverages advancements in algal genomics and molecular biology to create engineered microalgae that can produce affordable therapeutic proteins and vaccines. This innovative approach serves to reduce the reliance on antibiotics in farmed fish, addressing significant issues such as high fish mortality rates and the risk of bacterial and viral diseases that threaten fish stocks. By utilizing microalgae as a delivery vehicle for these vaccines, MicroSynbiotiX not only minimizes labor and production costs but also enhances the accessibility and effectiveness of vaccines, ultimately contributing to improved global food security.

SepPure disrupts energy-intensive chemical separation processes like distillation. It uses novel nanofiltration membranes for sustainable separations, reducing global energy consumption, emissions, and pollution.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

Founded in 2011, Dahlia Biosciences is a biotechnology company specializing in single-cell RNA analysis tools for research and diagnostic applications. It uses CRISPR-Cas9 technology to detect multiple DNA and RNA biomarkers directly in cells and tissues.

SepPure disrupts energy-intensive chemical separation processes like distillation. It uses novel nanofiltration membranes for sustainable separations, reducing global energy consumption, emissions, and pollution.

MicroSynbiotiX Limited, founded in 2016 and based in Cork City, Ireland, focuses on the development of oral vaccines specifically for the aquaculture sector. The company leverages advancements in algal genomics and molecular biology to create engineered microalgae that can produce affordable therapeutic proteins and vaccines. This innovative approach serves to reduce the reliance on antibiotics in farmed fish, addressing significant issues such as high fish mortality rates and the risk of bacterial and viral diseases that threaten fish stocks. By utilizing microalgae as a delivery vehicle for these vaccines, MicroSynbiotiX not only minimizes labor and production costs but also enhances the accessibility and effectiveness of vaccines, ultimately contributing to improved global food security.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2011, Dahlia Biosciences is a biotechnology company specializing in single-cell RNA analysis tools for research and diagnostic applications. It uses CRISPR-Cas9 technology to detect multiple DNA and RNA biomarkers directly in cells and tissues.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2011, Dahlia Biosciences is a biotechnology company specializing in single-cell RNA analysis tools for research and diagnostic applications. It uses CRISPR-Cas9 technology to detect multiple DNA and RNA biomarkers directly in cells and tissues.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

MicroSynbiotiX Limited, founded in 2016 and based in Cork City, Ireland, focuses on the development of oral vaccines specifically for the aquaculture sector. The company leverages advancements in algal genomics and molecular biology to create engineered microalgae that can produce affordable therapeutic proteins and vaccines. This innovative approach serves to reduce the reliance on antibiotics in farmed fish, addressing significant issues such as high fish mortality rates and the risk of bacterial and viral diseases that threaten fish stocks. By utilizing microalgae as a delivery vehicle for these vaccines, MicroSynbiotiX not only minimizes labor and production costs but also enhances the accessibility and effectiveness of vaccines, ultimately contributing to improved global food security.

Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

MicroSynbiotiX Limited, founded in 2016 and based in Cork City, Ireland, focuses on the development of oral vaccines specifically for the aquaculture sector. The company leverages advancements in algal genomics and molecular biology to create engineered microalgae that can produce affordable therapeutic proteins and vaccines. This innovative approach serves to reduce the reliance on antibiotics in farmed fish, addressing significant issues such as high fish mortality rates and the risk of bacterial and viral diseases that threaten fish stocks. By utilizing microalgae as a delivery vehicle for these vaccines, MicroSynbiotiX not only minimizes labor and production costs but also enhances the accessibility and effectiveness of vaccines, ultimately contributing to improved global food security.

ViaeX Technologies Inc. specializes in the development and manufacturing of bio-engineered nano-membrane technology solutions aimed at purifying water and air. The company's innovative biological nanofiltration systems are designed to be 400% more efficient than conventional methods, targeting specific pollutants and bacteria. These systems are biodegradable, cost-effective, and easily scalable, making them suitable for rapid deployment in cities facing significant pollution challenges. ViaeX's focus is on creating energy-efficient and environmentally friendly filtration systems that cater to industrial and municipal needs. The company's technological advancements are grounded in extensive research conducted at UC Berkeley and UC San Diego, utilizing breakthroughs in physical chemistry and nanotechnology. Additionally, ViaeX is developing sustainable nanomaterials from bio-waste, which can be applied across various industries, including water purification and food filtration, thereby reducing dependency on traditional materials and contributing to a more sustainable future.

Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and headquartered in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that utilizes proprietary nanoparticles with unique multilayered structures. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's approach aims to enhance the specificity, efficacy, and safety of cancer treatments, offering healthcare providers new opportunities in the fight against cancer.

ViaeX Technologies Inc. specializes in the development and manufacturing of bio-engineered nano-membrane technology solutions aimed at purifying water and air. The company's innovative biological nanofiltration systems are designed to be 400% more efficient than conventional methods, targeting specific pollutants and bacteria. These systems are biodegradable, cost-effective, and easily scalable, making them suitable for rapid deployment in cities facing significant pollution challenges. ViaeX's focus is on creating energy-efficient and environmentally friendly filtration systems that cater to industrial and municipal needs. The company's technological advancements are grounded in extensive research conducted at UC Berkeley and UC San Diego, utilizing breakthroughs in physical chemistry and nanotechnology. Additionally, ViaeX is developing sustainable nanomaterials from bio-waste, which can be applied across various industries, including water purification and food filtration, thereby reducing dependency on traditional materials and contributing to a more sustainable future.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

MicroSynbiotiX Limited, founded in 2016 and based in Cork City, Ireland, focuses on the development of oral vaccines specifically for the aquaculture sector. The company leverages advancements in algal genomics and molecular biology to create engineered microalgae that can produce affordable therapeutic proteins and vaccines. This innovative approach serves to reduce the reliance on antibiotics in farmed fish, addressing significant issues such as high fish mortality rates and the risk of bacterial and viral diseases that threaten fish stocks. By utilizing microalgae as a delivery vehicle for these vaccines, MicroSynbiotiX not only minimizes labor and production costs but also enhances the accessibility and effectiveness of vaccines, ultimately contributing to improved global food security.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and headquartered in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that utilizes proprietary nanoparticles with unique multilayered structures. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's approach aims to enhance the specificity, efficacy, and safety of cancer treatments, offering healthcare providers new opportunities in the fight against cancer.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

SouthWest NanoTechnologies, founded in 2001, specializes in the synthesis and commercialization of carbon nanotubes, particularly single-wall carbon nanotubes, using its proprietary CoMoCAT® technology developed by Professor Daniel Resasco. The company has established itself as a leading supplier of high-purity carbon nanotubes, catering to over 1,000 materials developers across diverse industries such as consumer electronics, energy storage, and composite manufacturing. Utilizing fluidized bed reactors, SouthWest NanoTechnologies employs a catalytic method that allows for precise control over the diameter, chirality, and purity of the nanotubes produced. This unique capability ensures that its carbon nanotubes possess exceptional thermal and chemical stability, making them suitable for a wide range of applications, including electronics, health care, and advanced composite materials.